These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9088978)

  • 41. Bruton's Tyrosine Kinase Is Not Essential for B Cell Survival beyond Early Developmental Stages.
    Nyhoff LE; Clark ES; Barron BL; Bonami RH; Khan WN; Kendall PL
    J Immunol; 2018 Apr; 200(7):2352-2361. PubMed ID: 29483358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.
    Cancro MP; Sah AP; Levy SL; Allman DM; Schmidt MR; Woodland RT
    Int Immunol; 2001 Dec; 13(12):1501-14. PubMed ID: 11717191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells.
    Nisitani S; Satterthwaite AB; Akashi K; Weissman IL; Witte ON; Wahl MI
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2737-42. PubMed ID: 10688914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of Btk in B cell development and signaling.
    Desiderio S
    Curr Opin Immunol; 1997 Aug; 9(4):534-40. PubMed ID: 9287186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
    Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
    Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. xid affects events leading to B cell cycle entry.
    Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
    J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insight into B cell development and differentiation.
    Moschese V; Orlandi P; Di Matteo G; Chini L; Carsetti R; Di Cesare S; Rossi P
    Acta Paediatr Suppl; 2004 May; 93(445):48-51. PubMed ID: 15176720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in Bruton's tyrosine kinase impair IgA responses.
    Mitsuiki N; Yang X; Bartol SJ; Grosserichter-Wagener C; Kosaka Y; Takada H; Imai K; Kanegane H; Mizutani S; van der Burg M; van Zelm MC; Ohara O; Morio T
    Int J Hematol; 2015 Mar; 101(3):305-13. PubMed ID: 25589397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bruton's tyrosine kinase is required for TLR-induced IL-10 production.
    Schmidt NW; Thieu VT; Mann BA; Ahyi AN; Kaplan MH
    J Immunol; 2006 Nov; 177(10):7203-10. PubMed ID: 17082638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.
    Yamadori T; Baba Y; Matsushita M; Hashimoto S; Kurosaki M; Kurosaki T; Kishimoto T; Tsukada S
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6341-6. PubMed ID: 10339589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced formation of phosphatidic acid upon B-cell receptor triggering of mouse B-lymphocytes lacking Bruton's tyrosine kinase.
    Forssell J; Nilsson A; Sideras P
    Scand J Immunol; 2000 Jul; 52(1):30-8. PubMed ID: 10886781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
    de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
    Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity.
    Fukuda M; Kojima T; Kabayama H; Mikoshiba K
    J Biol Chem; 1996 Nov; 271(48):30303-6. PubMed ID: 8939985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation.
    Wang SP; Iwata S; Nakayamada S; Niiro H; Jabbarzadeh-Tabrizi S; Kondo M; Kubo S; Yoshikawa M; Tanaka Y
    Rheumatology (Oxford); 2015 Aug; 54(8):1488-97. PubMed ID: 25724205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation.
    Haxhinasto SA; Bishop GA
    J Biol Chem; 2004 Jan; 279(4):2575-82. PubMed ID: 14604983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse.
    Dingjan GM; Middendorp S; Dahlenborg K; Maas A; Grosveld F; Hendriks RW
    J Exp Med; 2001 May; 193(10):1169-78. PubMed ID: 11369788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase.
    Cory GO; Lovering RC; Hinshelwood S; MacCarthy-Morrogh L; Levinsky RJ; Kinnon C
    J Exp Med; 1995 Aug; 182(2):611-5. PubMed ID: 7629518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function.
    Gagliardi MC; Finocchi A; Orlandi P; Cursi L; Cancrini C; Moschese V; Miyawaki T; Rossi P
    Clin Exp Immunol; 2003 Jul; 133(1):115-22. PubMed ID: 12823285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.